Viemed Healthcare VMD Income Statement (2018-2026)

NASDAQ VMD
$8.98 +0.03 (+0.34%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Viemed Healthcare Quarterly Income Statement

Periods 35 quarters
Latest Sep 2026

Viemed Healthcare reported revenue of $80.67M and net income of $4.74M for the quarter ended Sep 2026, up 12.2% year over year. This income statement covers 35 quarters of results from Mar 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
31.96M32.26M33.31M35.76M37.51M39.56M43.31M49.40M50.74M50.59M54.97M58.00M60.70M59.13M63.06M71.91M76.18M75.41M78.10M80.67M
Cost of RevenueCost of Rev
12.30M12.51M12.92M14.11M14.61M15.55M17.21M18.84M18.63M20.79M22.07M23.63M24.56M25.85M26.33M30.57M32.08M32.59M33.05M34.48M
Gross Profit
19.66M19.74M20.39M21.65M22.90M24.00M26.11M30.56M32.11M29.80M32.89M34.37M36.14M33.28M36.73M41.35M44.10M42.83M45.05M46.19M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
3.12M3.40M0.24M0.29M4.37M4.76M0.30M0.42M
Research & DevelopmentR&D
0.61M0.63M0.67M0.67M0.72M0.78M0.76M0.59M0.65M0.75M0.76M0.76M0.80M0.80M0.85M0.78M0.60M0.58M0.50M0.50M
Share-based Compensation (IS)Stock Comp.
1.31M1.31M1.27M1.31M1.32M1.39M1.47M1.45M1.53M1.43M1.62M1.71M1.52M2.31M2.34M2.18M2.30M2.45M2.03M2.48M
Selling, General & AdministrativeSG&A
14.24M15.78M17.54M17.68M17.17M19.76M20.56M23.65M23.91M24.81M26.50M26.67M28.21M28.43M28.80M31.92M32.22M34.79M37.13M35.51M
Other Operating ExpensesOther Opex
Operating ExpensesOpex
17.97M19.81M18.45M18.64M22.27M25.30M21.62M24.67M24.56M25.56M27.26M27.43M29.01M29.22M29.65M32.69M32.82M35.37M37.64M36.01M
Operating IncomeOp. Inc
4.67M2.25M1.00M1.47M3.53M1.93M2.90M4.21M5.29M2.20M3.62M5.63M6.45M3.84M5.10M5.64M8.37M4.30M4.46M6.96M
Non-operating items
Non Operating Interest Expenses
0.18M0.13M0.31M0.25M0.18M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
-0.14M0.01M0.11M-0.29M-0.18M0.02M-0.12M-0.28M-0.27M-0.21M0.55M0.47M1.10M2.37M0.64M-0.48M-0.29M-0.36M-0.60M-0.41M
Other Non Operating IncomeOther Non Op Inc.
1.54M0.44M0.22M0.06M0.27M0.08M0.00M0.04M-0.03M0.03M-0.56M0.28M0.09M0.08M0.07M0.04M0.06M0.04M0.07M0.06M
Net income details
EBIT
4.67M2.25M1.00M1.47M3.53M1.93M2.90M4.21M5.29M2.20M3.62M5.63M6.45M3.84M5.10M5.64M8.37M4.30M4.46M6.96M
EBT
5.06M2.51M1.39M1.51M3.58M2.02M3.06M4.24M5.08M2.12M2.25M5.50M6.31M3.66M4.96M5.14M8.01M3.99M4.05M6.79M
Tax ProvisionsTaxes
0.97M0.75M0.42M0.46M1.15M0.50M0.73M1.32M1.60M0.52M0.77M1.59M1.88M0.95M1.71M1.54M2.19M1.30M1.15M2.05M
Income After Tax
4.09M1.76M0.97M1.06M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.91M4.42M2.71M3.25M3.60M5.82M2.69M2.90M4.74M
Equity Income
0.46M0.32M0.45M0.08M0.08M0.04M0.14M0.27M0.04M0.07M-1.12M0.10M
Income from Continuing OperationsIncome (Continuing)
4.09M1.76M0.97M1.06M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.91M4.42M2.71M3.25M3.60M5.82M2.69M2.90M4.74M
Consolidated Net IncomeConsol Net Inc.
4.09M1.76M0.97M1.06M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.91M4.42M2.71M3.25M3.60M5.82M2.71M2.90M4.74M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
0.01M0.03M0.11M0.09M0.09M0.09M0.18M0.13M0.14M0.10M
Income towards Parent CompanyParent Net Inc
4.09M1.76M0.97M1.06M2.44M1.52M2.33M2.92M3.48M1.60M1.47M3.88M4.32M2.63M3.16M3.51M5.64M2.58M2.76M4.64M
Net Income towards Common StockholdersNet Income
4.09M1.76M0.97M1.06M2.44M1.52M2.33M2.92M3.48M1.60M1.47M3.88M4.32M2.63M3.16M3.51M5.64M2.58M2.76M4.64M
Additional items
EPS (Basic)
0.100.040.020.030.060.040.060.080.090.040.040.100.110.070.080.090.140.070.070.12
EPS (Diluted)
0.100.040.020.030.060.040.060.070.090.040.040.100.110.060.080.090.140.060.070.11
Shares Outstanding
39.49M39.62M38.77M38.23M38.66M38.16M38.32M38.44M38.35M38.72M38.82M38.87M38.75M39.43M39.52M38.64M38.90M38.43M38.25M38.10M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
40.68M40.36M39.75M39.58M39.81M40.02M40.68M40.42M40.38M40.58M40.55M40.78M40.81M41.63M41.08M40.50M40.82M40.49M41.13M41.19M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
39.64M39.29M38.22M38.10M38.05M38.28M38.40M38.49M38.51M38.82M38.83M38.93M39.13M39.52M39.61M38.02M38.02M38.53M38.09M38.05M
EBITDA
7.79M5.65M4.74M5.59M7.91M6.70M8.11M10.18M11.21M8.49M10.01M12.09M12.87M10.49M12.02M13.24M16.05M11.98M12.05M14.75M
Interest ExpensesInt Expense
0.18M0.13M0.31M0.25M0.18M
Tax Rate
19.15%29.72%30.33%30.18%31.98%24.83%23.81%31.14%31.50%24.42%34.21%28.99%29.83%26.00%34.52%29.89%27.36%32.57%28.41%30.18%

Viemed Healthcare Income Statement API

Pull Viemed Healthcare's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VMD&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY